The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
Official Title: Neoadjuvant Hormone Therapy for Postmenopausal Women With HR+ Primary Breast Cancer: A Multi-center Study to Determine the Optimum Length of Treatment With Letrozole on Tumour Regression to Permit Breast Conserving Surgery.
Study ID: NCT00330317
Brief Summary: The aim of this study is to assess the safety and efficacy of neoadjuvant hormone therapy with letrozole in postmenopausal women with estrogen- and/or progesterone-receptor positive primary breast cancer on tumour regression to permit breast conserving surgery.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Novartis Investigative Site, Bournemouth, , United Kingdom
Novartis Investigative Site, Brighton, , United Kingdom
Novartis Investigative Site, Bristol, , United Kingdom
Novartis Investigative Site, Crewe, , United Kingdom
Novartis Investigative Site, Dundee, , United Kingdom
Novartis Investigative Site, East Sussex, , United Kingdom
Novartis Investigative Site, Epping, , United Kingdom
Novartis Investigative Site, Farnworth, , United Kingdom
Novartis Investigative Site, Gateshead, , United Kingdom
Novartis Investigative Site, Glasgow, , United Kingdom
Novartis Investigative Site, Hants, , United Kingdom
Novartis Investigative Site, Leicester, , United Kingdom
Novartis Investigative Site, Liverpool, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, Luton, , United Kingdom
Novartis Investigative Site, Manchester, , United Kingdom
Novartis Investigative Site, Newcastle, , United Kingdom
Novartis Investigative Site, Poole, , United Kingdom
Novartis Investigative Site, St. Leonards on Sea, , United Kingdom
Novartis Investigative Site, West Smithfield, , United Kingdom
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmeceuticals
Role: STUDY_DIRECTOR